Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $375.33 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $113.59 | 1 | $0 (2019) |
| ABBVIE INC. | $83.03 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $73.47 | 2 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $39.84 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $34.24 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $15.87 | 1 | $0 (2023) |
| ITI, Inc. | $15.29 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $89.91 | 3 | Neurocrine Biosciences, Inc. ($39.84) |
| 2023 | $171.83 | 5 | ABBVIE INC. ($83.03) |
| 2019 | $113.59 | 1 | Allergan Inc. ($113.59) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/26/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $39.84 | General |
| Category: Neuropsychiatry | ||||||
| 01/31/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Neuroscience | ||||||
| 12/13/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Neurology | ||||||
| 07/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $83.03 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $43.47 | General |
| Category: Neuroscience | ||||||
| 11/06/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $113.59 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 273 | 661 | $241,824 | $56,878 |
| 2022 | 7 | 306 | 598 | $214,432 | $53,126 |
| 2021 | 5 | 317 | 606 | $206,213 | $55,826 |
| 2020 | 2 | 29 | 30 | $13,830 | $4,558 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 254 | $56,896 | $16,089 | 28.3% |
| 90870 | Therapy using electrical currents | Facility | 2023 | 12 | 126 | $60,480 | $10,638 | 17.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 73 | 75 | $46,050 | $10,360 | 22.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 96 | $30,816 | $8,889 | 28.8% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 45 | 50 | $27,100 | $6,591 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 47 | $15,698 | $3,156 | 20.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 11 | 13 | $4,784 | $1,156 | 24.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 78 | 280 | $62,720 | $16,059 | 25.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 81 | 85 | $52,190 | $13,369 | 25.6% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 69 | 80 | $43,360 | $11,104 | 25.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 43 | 70 | $22,470 | $5,814 | 25.9% |
| 90870 | Therapy using electrical currents | Facility | 2022 | 12 | 36 | $17,280 | $3,120 | 18.1% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 11 | 21 | $7,728 | $2,076 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 26 | $8,684 | $1,583 | 18.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 117 | 138 | $66,930 | $18,945 | 28.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 82 | 293 | $65,632 | $17,299 | 26.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 52 | 107 | $34,347 | $8,995 | 26.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 34 | 34 | $20,876 | $5,594 | 26.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 32 | 34 | $18,428 | $4,994 | 27.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 14 | $6,198 | $2,372 | 38.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 15 | 16 | $7,632 | $2,186 | 28.6% |
About Dr. Doriana Morar, MD
Dr. Doriana Morar, MD is a Psychiatry healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508074188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Doriana Morar, MD has received a total of $375.33 in payments from pharmaceutical and medical device companies, with $89.91 received in 2024. These payments were reported across 9 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($375.33).
As a Medicare-enrolled provider, Morar has provided services to 925 Medicare beneficiaries, totaling 1,895 services with total Medicare billing of $170,388. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Providence, RI
- Active Since 05/18/2007
- Last Updated 04/02/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1508074188
Products in Payments
- VRAYLAR (Drug) $196.62
- SPRAVATO (Drug) $43.47
- INGREZZA (Drug) $39.84
- INVEGA SUSTENNA (Drug) $30.00
- ABILIFY MAINTENA (Drug) $20.07
- UZEDY (Drug) $15.87
- CAPLYTA (Drug) $15.29
- REXULTI (Drug) $14.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Providence
Dr. James Greer, Md, MD
Psychiatry — Payments: $727,742
Linda Carpenter, Md, MD
Psychiatry — Payments: $43,650
Brian Ackerman
Psychiatry — Payments: $9,878
Steven Rasmussen, Md, MD
Psychiatry — Payments: $6,302
Kazi Salahuddin, Md, MD
Psychiatry — Payments: $4,840
Katharine Phillips, Md, MD
Psychiatry — Payments: $4,723